National Microbiology Laboratory
Runtao He has not added Biography.
If you are Runtao He and would like to personalize this page please email our Author Liaison for assistance.
Activation of AP-1 signal transduction pathway by SARS coronavirus nucleocapsid protein.
Biochemical and biophysical research communications Nov, 2003 | Pubmed ID: 14623261
Analysis of multimerization of the SARS coronavirus nucleocapsid protein.
Biochemical and biophysical research communications Apr, 2004 | Pubmed ID: 15020242
Potent and selective inhibition of SARS coronavirus replication by aurintricarboxylic acid.
Biochemical and biophysical research communications Aug, 2004 | Pubmed ID: 15249217
Characterization of protein-protein interactions between the nucleocapsid protein and membrane protein of the SARS coronavirus.
Virus research Oct, 2004 | Pubmed ID: 15351485
Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets.
Journal of virology Nov, 2004 | Pubmed ID: 15507655
Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets.
Vaccine Mar, 2005 | Pubmed ID: 15755610
Structural analysis of inhibition mechanisms of aurintricarboxylic acid on SARS-CoV polymerase and other proteins.
Computational biology and chemistry Jun, 2005 | Pubmed ID: 15979041
Aurintricarboxylic acid inhibits the early stage of vaccinia virus replication by targeting both cellular and viral factors.
Journal of virology Mar, 2007 | Pubmed ID: 17192307
Conformational reorganization of the SARS coronavirus spike following receptor binding: implications for membrane fusion.
PloS one , 2007 | Pubmed ID: 17957264
Mammalian two-hybrid assay for detecting protein-protein interactions in vivo.
Methods in molecular biology (Clifton, N.J.) , 2008 | Pubmed ID: 18370113
Comparison of trichloroacetic acid with other protein-precipitating agents in enriching abnormal prion protein for Western blot analysis.
Canadian journal of microbiology Jun, 2008 | Pubmed ID: 18535632
Universal antibodies and their applications to the quantitative determination of virtually all subtypes of the influenza A viral hemagglutinins.
Vaccine Nov, 2008 | Pubmed ID: 19007587
The SR-rich motif in SARS-CoV nucleocapsid protein is important for virus replication.
Canadian journal of microbiology Mar, 2009 | Pubmed ID: 19370068
The interaction between thymine DNA glycosylase and nuclear receptor coactivator 3 is required for the transcriptional activation of nuclear hormone receptors.
Molecular and cellular biochemistry Jan, 2010 | Pubmed ID: 19652917
A simple slot blot for the detection of virtually all subtypes of the influenza A viral hemagglutinins using universal antibodies targeting the fusion peptide.
Nature protocols , 2010 | Pubmed ID: 20010723
Aurintricarboxylic acid is a potent inhibitor of influenza A and B virus neuraminidases.
PloS one , 2009 | Pubmed ID: 20020057
Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences.
Vaccine Aug, 2010 | Pubmed ID: 20621113
Nigericin is a potent inhibitor of the early stage of vaccinia virus replication.
Antiviral research Dec, 2010 | Pubmed ID: 20951746
Universal antibodies against the highly conserved influenza fusion peptide cross-neutralize several subtypes of influenza A virus.
Biochemical and biophysical research communications Dec, 2010 | Pubmed ID: 21078301
Bioactivity determination of native and variant forms of therapeutic interferons.
Journal of biomedicine & biotechnology , 2011 | Pubmed ID: 21403871
Acute hepatitis as a manifestation of parvovirus B19 infection.
Journal of clinical microbiology Sep, 2011 | Pubmed ID: 21734024
Rapid and accurate determination of the potency of varicella vaccine by quantitative polymerase chain reaction.
Vaccine Nov, 2011 | Pubmed ID: 21939719
GOmotif: A web server for investigating the biological role of protein sequence motifs.
BMC bioinformatics , 2011 | Pubmed ID: 21943350
Caroline Gravel*,1,
Changgui Li*,2,
Junzhi Wang2,
Anwar M Hashem1,3,4,
Bozena Jaentschke1,
Gary Van Domselaar5,
Runtao He5,
Xuguang Li1,3
1Centre for Vaccine Evaluation, Biologics and Genetic Therapies Directorate, HPFB, Health canada,
2National Institute for the Control of Pharmaceutical and Biological Products, The State Food and Drug Administration, Beijing,
3Department of Biochemistry, Microbiology and Immunology, University of Ottawa,
4Microbiology Department, Faculty of Medicine, King Abdulaziz University,
5National Microbiology Laboratory, Public Health Agency of Canada